Daniel Vella Friggieri, Regional CEO of Aspen Pharma’s Middle East, North Africa, and Turkey (MENAT) markets, was awarded the ‘Executive of the Year’ title by the company.
Mr Vella Friggieri joined Aspen Pharma in 2016 as Managing Director of the company’s Middle East and North Africa markets. Three years later, he was promoted to his current role.
“I am humbled and honoured to accept the Aspen Pharma Group Executive of the Year award,” the Regional CEO wrote on social media.
“I dedicate this award to all the MENAT team for their trust and resilience every day,” he continued.
Headquartered in Durban, South Africa, Aspen Pharma is a global speciality and branded pharmaceutical company.
Mr Vella Friggieri has a wealth of experience in local and international pharmaceutical industries.
Before joining Aspen Pharma, he held a lengthy tenure at Actavis (now Allergan). He joined the company as Country Manager for Malta and he steadily worked his way up to Regional Director for the North Africa and Levan regions.
Mohammed Louhab’s appointment as new FIMBank Group CEO granted regulatory approval
He takes over from Alejandro Gosttuski, who will now take on the role of an Advisor.
Mark Curmi named CEO at upcoming fintech provider Trumia
The company, set to launch soon, will seek to provide clients with ‘customer-centric and innovative’ financial services.
MSE CEO Simon Zammit highlights exchanges’ ‘pivotal role’ in addressing sustainability
The Malta Stock Exchange recently joined other exchanges for the inaugural Ring the Bell for Climate initiative.
A family charter acts as a ‘compass’ to guide family businesses through ‘evolution and succession’
Family businesses account for more than 70% of Malta’s SMEs, and are hence vital components of the local economy.
